SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report: August 28, 2001
PATHOBIOTEK DIAGNOSTICS INC.
---------------------------------------------------
(Exact name of registrant as specified in its charter)
Texas 000-28519 76-0510754
- ------------------ ---------------- ------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
4800 Research Forest Drive, The Woodlands, TX 77381- 4142
- --------------------------------------------- -----------
(Address of principal executive offices) (Postal Code)
Registrant's telephone number, including area code: (281) 364-6054
--------------
Item 1. Changes in Control of Registrant
None.
Item 2. Acquisition or Disposition of Assets
None.
Item 3. Bankruptcy or Receivership
None.
Item 4. Changes in Registrant's Certifying Accountant
None.
Item 5. Other Events
Effective as of September 7, 2001, shares of the Company's
Common Stock have been reverse-split, one new share for forty old shares, except
no shareholder shall be reduced to less than 10 shares.
Item 6. Resignation and Appointment of Directors
None.
Item 7. Financial Statements, Pro Forma Financials, & Exhibits
None.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Date: August 28, 2001 PATHOBIOTEK DIAGNOSTICS, INC.
By: /s/ Robert C. Simpson
--------------------------------------
Robert C. Simpson, President